- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06542978
Effect of Prophylactic Application of 40Hz Transcranial Stimulation in AICU on Incidence of Postoperative Delirium in Elderly Patients Undergoing Elective Gastrointestinal Surgery
October 24, 2024 updated by: Henan Provincial People's Hospital
Postoperative delirium is an acute central nervous system dysfunction caused by surgical stress, which is manifested by postoperative acute, non-specific changes in consciousness level, attention, cognitive ability and disturbance of sleep and wake cycles.
It is one of the most common surgical complications in the elderly, occurring in more than 75% of patients receiving mechanical ventilation in the intensive care unit(ICU).Exogenous 40 Hz stimulation can improve cognitive functioning.Therefore, the aim of this study was to investigate the effect of exogenous 40Hz stimulation on the incidence of postoperative delirium in elderly patients undergoing elective gastrointestinal surgery in AICU.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
98
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zhang jiaqiang
- Phone Number: 037165580728
- Email: hnmzxh@163.com
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China
- Recruiting
- Henan People's Hospital
-
Contact:
- Zhang jiaqiang
- Phone Number: 037165580728
- Email: hnmzxh@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 1.Age ≥ 65 years old,gender not limited
- 2.ASA classification Ⅱ ~ Ⅳ
- 3.Elective gastrointestinal general anesthesia surgery
Exclusion Criteria:
- 1.History of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis
- 2.Pre-operative coma, severe dementia, speech impairment or severe illness incapacitated and unable to communicate
- 3.Delirium on admission or pre-operative delirium, brain injury
- 4.Severely infected person
- 5.Severe liver dysfunction (Child-Pugh C), severe renal insufficiency (preoperative dialysis)
- 6.Severe hearing or vision impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
After admission to AICU, the control group was not stimulated at 40Hz ;
|
|
|
Experimental: 40Hz stimulation group
After admission to AICU, the experimental group was stimulated at 40Hz for 6h;
|
Exogenous 40HZ stimulation is a physical intervention that can drive oscillations in the gamma range, and the oscillations and pulses caused at the corresponding frequency can lead to a significant reduction in β-amyloid, reverse tau hyperphosphorylation, and thereby improve the cognitive function of patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The incidence of postoperative delirium
Time Frame: Day 1, Day 2, Day 3 ,Day 4, Day 5, Day 6,Day 7 after surgery
|
Postoperative delirium was assessed using the CAM-ICU scale.The RASS score (The Richmond Agitation-Sedation Scale) was used to assess arousal.
When the patient's RASS score is not -4 /-5, delirium evaluation can continue considering the patient's wakefulness status.CAM-ICU scale contains four features (Feature 1, Feature 2, Feature 3, and Feature 4).
Delirium can be diagnosed when the patient is positive for features 1, 2, 3, or 4.
|
Day 1, Day 2, Day 3 ,Day 4, Day 5, Day 6,Day 7 after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Markers
Time Frame: half hour, 6hours, 24hours and 48hours after transfer to aicu
|
Serum Tau proteomic analysis and CRP, IL-6, and TNF-ɑ were recorded
|
half hour, 6hours, 24hours and 48hours after transfer to aicu
|
|
Sleep quality
Time Frame: 8:00 to 10:00 every morning for the first three days after surgery
|
The Chinese version of the Richards-Campbell Sleep Quality Scale Score (RCSQ) was used to evaluate sleep quality.
RCSQ scoring average for five projects, including 0 ~ 25 points on behalf of the poor quality of sleep, on behalf of the sleep quality of 76 ~ 100 points; The higher the score says sleep quality, the better
|
8:00 to 10:00 every morning for the first three days after surgery
|
|
The incidence of pain
Time Frame: 6hours, 24hours, 48hours after surgery
|
Mark a 0-10cm horizontal line on the paper with a ruler, and determine the score in millimeters (mm).
The score range is 0-100mm, and the higher the score, the greater the pain intensity; No pain (0-4 mm), mild pain (5-44 mm), moderate pain (45-74 mm), severe pain (75-100 mm).
|
6hours, 24hours, 48hours after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2024
Primary Completion (Estimated)
March 1, 2025
Study Completion (Estimated)
March 1, 2025
Study Registration Dates
First Submitted
July 23, 2024
First Submitted That Met QC Criteria
August 3, 2024
First Posted (Actual)
August 7, 2024
Study Record Updates
Last Update Posted (Actual)
October 28, 2024
Last Update Submitted That Met QC Criteria
October 24, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Henan FYX
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Delirium
-
Wonkwang University HospitalCompleted
-
Sengkang General HospitalRecruitingDelirium and Post-operative Cognitive Dysfunction (POCD) | Delirium, Postoperative | Delirium - PostoperativeSingapore
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingPostoperative Delirium (POD)China
-
Qin ZhangNational Natural Science Foundation of ChinaRecruiting
-
Qin ZhangNational Natural Science Foundation of ChinaRecruitingDelirium, PostoperativeChina
-
Hao LiCompleted
-
Chinese PLA General HospitalXiangya Hospital of Central South University; The Affiliated Nanjing Drum Tower... and other collaboratorsCompletedPostoperative Delirium (POD)China
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyCompletedPostoperative Delirium (POD)Switzerland
-
Riverside University Health System Medical CenterNot yet recruitingPostoperative Delirium (POD) | Norepinephrine | Ephedrine
-
Konya City HospitalCompletedPREOPERATIVE SLEEP QUALITY ON POSTOPERATIVE DELIRIUMTurkey
Clinical Trials on 40Hz stimulation
-
Ruijin HospitalRecruiting
-
Barts & The London NHS TrustBoston Scientific CorporationCompleted
-
Henan Provincial People's HospitalRecruitingPostoperative Delirium | Elderly | AnesthesiaChina
-
Henan Provincial People's HospitalCompletedChildren | Emergence Delirium | AnesthesiaChina
-
Taipei Hospital, Ministry of Health and WelfareCompletedDementia | Cognitive Impairment, MildTaiwan
-
Clarity Health Technologies, IncParc de Salut MarNot yet recruiting
-
Alzheimer's Light LLCRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognition Disorders in Old AgeUnited States
-
Shirley Ryan AbilityLabNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Nonfluent AphasiaUnited States
-
National Council of Scientific and Technical Research...Completed
-
Clinique Beau SoleilNot yet recruiting